Unknown

Dataset Information

0

PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma.


ABSTRACT: New treatments for glioblastoma multiforme (GBM) are desperately needed, as GBM prognosis remains poor, mainly due to treatment resistance, poor distribution of therapeutics in the tumor tissue, and fast metabolism of chemotherapeutic drugs in the brain extracellular space. Convection-enhanced delivery (CED) of nanoparticles (NPs) has been shown to improve the delivery of chemotherapeutic drugs to the tumor bed, providing sustained release, and enhancing survival of animals with intracranial tumors. Here we administered gemcitabine, a nucleoside analog used as a first line treatment for a wide variety of extracranial solid tumors, within squalene-based NPs using CED, to overcome the above-mentioned challenges of GBM treatment. Small percentages of poly(ethylene) glycol (PEG) dramatically enhanced the distribution of squalene-gemcitabine nanoparticles (SQ-Gem NPs) in healthy animals and tumor-bearing animals after administration by CED. When tested in an orthotopic model of GBM, SQ-Gem-PEG NPs demonstrated significantly improved therapeutic efficacy compared to free gemcitabine, both as a chemotherapeutic drug and as a radiosensitizer. Furthermore, MR contrast agents were incorporated into the SQ-Gem-PEG NP formulation, providing a way to non-invasively track the NPs during infusion.

SUBMITTER: Gaudin A 

PROVIDER: S-EPMC5072177 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma.

Gaudin Alice A   Song Eric E   King Amanda R AR   Saucier-Sawyer Jennifer K JK   Bindra Ranjit R   Desmaële Didier D   Couvreur Patrick P   Saltzman W Mark WM  

Biomaterials 20160804


New treatments for glioblastoma multiforme (GBM) are desperately needed, as GBM prognosis remains poor, mainly due to treatment resistance, poor distribution of therapeutics in the tumor tissue, and fast metabolism of chemotherapeutic drugs in the brain extracellular space. Convection-enhanced delivery (CED) of nanoparticles (NPs) has been shown to improve the delivery of chemotherapeutic drugs to the tumor bed, providing sustained release, and enhancing survival of animals with intracranial tum  ...[more]

Similar Datasets

| S-EPMC4727823 | biostudies-literature
| S-EPMC4351925 | biostudies-literature
| S-EPMC10298353 | biostudies-literature
| S-EPMC7500584 | biostudies-literature
| S-EPMC4168894 | biostudies-literature
| S-EPMC10054028 | biostudies-literature
| S-EPMC6701990 | biostudies-literature
| S-EPMC8781388 | biostudies-literature
| S-EPMC7943818 | biostudies-literature
| S-EPMC4534517 | biostudies-literature